Penumbra Class I Recall Again Raises Concerns About 510(k) Pathway, Device Creep
Executive Summary
A case study of the Penumbra JET 7 class I recall in JAMA has again raised concerns about shortcomings in the US FDA’s 510(k) pathway in the medical community.
You may also be interested in...
Recall Chances Higher For 510(k) Devices With Recalled Predicates, Studies Show
Two studies recently published in JAMA argue that a higher recall rate tied to 510(k) devices cleared based on also-recalled predicate devices help to demonstrate 510(k) safety concerns.
US FDA Proposes Independent Contractor To Track User Fee Dollars Used To Pay FTEs
The agency published minutes from three MDUFA V user fee meetings with medtech industry. The talks include conversations about carryover funds and filling FTEs from past user fee deals.
FDA Official: Uptick In PMA, 510(k) Applications Calls For More User Fee Dollars
The number of PMA and 510(k) applications have been steadily growing and becoming harder to review as they’ve become more complex – which an FDA official says means the agency needs more financial resources.